Heterocyclic compound
AssigneeTakeda Pharmaceutical Company Limited
InventorsYasutomi Asano, Takuto Kojima, Osamu Kurasawa, Tzu-Tshin Wong, Yasuhiro Hirata, Naoki Iwamura, Bunnai Saito, Yuta Tanaka, Ryosuke Arai, Shinichi Imamura, Kazuko Yonemori, Yasufumi Miyamoto, Shuji Kitamura, Osamu Sano
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).
Claims5
A method for treating Niemann-Pick disease in a mammal, comprising administering an effective amount of a compound or a salt thereof to the mammal, wherein the compound is represented by a formula:
- wherein
- ring Ar represents an optionally further substituted aromatic heterocycle or an optionally further substituted C6-14 aromatic hydrocarbon ring;
- ring A represents an optionally further substituted C6-14 aromatic hydrocarbon ring or an optionally further substituted heterocycle;
- R1 represents an optionally substituted C6-14 aryl group, an optionally substituted C3-10 cycloalkyl group or an optionally substituted heterocyclic group
- except that when R1 is an optionally substituted heterocyclic group, R1 is represented by a formula:
- wherein ring B represents an optionally further substituted heterocycle, and
- represents a single bond or a double bond, or a formula:
- wherein ring D represents an optionally further substituted nitrogen-containing heterocycle,
- R2 represents a hydrogen atom, or
- R1 and R2 are bonded to each other to form an optionally substituted 5- or 6-membered aromatic heterocycle or an optionally substituted benzene ring.
Dependencies are inferred from the claim text.